Gabelli Funds LLC boosted its stake in Vitamin Shoppe Inc (NYSE:VSI) by 369.7% during the third quarter, Holdings Channel.com reports. The fund owned 516,656 shares of the specialty retailer’s stock after purchasing an additional 406,656 shares during the quarter. Gabelli Funds LLC’s holdings in Vitamin Shoppe were worth $3,369,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in VSI. Cetera Advisors LLC acquired a new stake in Vitamin Shoppe during the 2nd quarter worth $47,000. State of Alaska Department of Revenue boosted its stake in Vitamin Shoppe by 124.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 11,834 shares of the specialty retailer’s stock worth $77,000 after purchasing an additional 6,564 shares during the last quarter. Smith Asset Management Group LP acquired a new stake in Vitamin Shoppe during the 2nd quarter worth $99,000. Pacer Advisors Inc. boosted its stake in Vitamin Shoppe by 14.2% during the 2nd quarter. Pacer Advisors Inc. now owns 42,666 shares of the specialty retailer’s stock worth $168,000 after purchasing an additional 5,303 shares during the last quarter. Finally, Crossmark Global Holdings Inc. boosted its stake in Vitamin Shoppe by 6.9% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 44,680 shares of the specialty retailer’s stock worth $176,000 after purchasing an additional 2,890 shares during the last quarter. 92.39% of the stock is currently owned by hedge funds and other institutional investors.
VSI remained flat at $$6.47 on Friday. 317,361 shares of the company’s stock traded hands, compared to its average volume of 536,362. Vitamin Shoppe Inc has a 52 week low of $3.32 and a 52 week high of $8.85. The company has a debt-to-equity ratio of 2.37, a quick ratio of 0.23 and a current ratio of 1.18. The firm’s fifty day simple moving average is $6.56 and its 200-day simple moving average is $5.44. The company has a market capitalization of $155.69 million, a PE ratio of 24.88 and a beta of 1.59.
Several equities research analysts have issued reports on the stock. ValuEngine raised shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a research note on Thursday, August 8th. Zacks Investment Research cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Featured Story: Most Active Stocks
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc (NYSE:VSI).
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.